chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm ache; Body ache; Temperature of 100.3; lips blistered; little shortness of breath; stuffy nose; chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm ache), MYALGIA (Body ache), PYREXIA (Temperature of 100.3), LIP BLISTER (lips blistered) and DYSPNOEA (little shortness of breath) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE PAIN (Arm ache), MYALGIA (Body ache), PYREXIA (Temperature of 100.3), LIP BLISTER (lips blistered), DYSPNOEA (little shortness of breath), NASAL CONGESTION (stuffy nose) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Arm ache), MYALGIA (Body ache), PYREXIA (Temperature of 100.3), LIP BLISTER (lips blistered), DYSPNOEA (little shortness of breath), NASAL CONGESTION (stuffy nose) and CHILLS (chills) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Body temperature: 100.3 (High) 100.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications are provided.
This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 92-year-old female patient who received SHINGRIX (batch number PK9BY, expiry date 19th March 2021) for prophylaxis. Previously administered products included SHINGRIX (1st dose received on 11th June 2018; batch number: 3AF9E, expiry date: 2nd February 2021). On 1st October 2018, the patient received the 2nd dose of SHINGRIX. In October 2018, less than a month after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were reported as follows: The pharmacist reports a patient was diagnosed as having shingles after receiving their second dose in series of SHINGRIX. It was reported that the patient was seen and treated by their a physician, however patient's current condition was unknown. No further details were reported regarding the event.
she experienced hand and feet itching/her arm is itchy; she noticed red streaks and splotches going up her arm to her elbows; she noticed red streaks and splotches going up her arm to her elbows; her arm started stinging; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), via an unspecified route of administration on 13Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that she received the first dose of the vaccine on 13Jan2021 and after the vaccine, she experienced hand and feet itching that lasted a few days in Jan2021. On Thursday and Friday after receiving the vaccine, she took Benadryl and put Cortisone on her hands. She then went to her doctor who prescribed her a medication and the Pharmacist told her it was Benadryl. She took the medication for 5 days and the medication stopped the itching. Today (as reported), her hands were itchy and she noticed red streaks and splotches going up her arm to her elbows and her arm was itchy, in Jan2021. Her arm started stinging as well while working at the dentist office today (as reported). Patient would like to know if she should receive the second dose as she was scheduled to receive the second dose on 03Feb2021. Outcome of events was unknown.  Information on the batch/lot number has been requested.
Approximately 1 1/2-2 hrs post injection, patient vomited one time and became very shaky. Hands shook hard enough that patient was unable to shave. Shaking continued to about 8pm. Patient states he was fine the next morning.
Mom states toddler had fever, 7 days post vax. Cried and lacked appetite for 5-6 days duration. Mom noticed swelling on left side of neck below ear on 12/11/00 and appetite improved, alert, active and happy. On 12/28/00, swelling still persists and is hard to the touch.
soreness; Tiredness; This spontaneous case was reported by a nurse and describes the occurrence of MYALGIA (soreness) and FATIGUE (Tiredness) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Seafood allergy (Allergic to shrimp), Drug allergy (Cold medications) and Blood pressure inadequately controlled.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (soreness) and FATIGUE (Tiredness). At the time of the report, MYALGIA (soreness) and FATIGUE (Tiredness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient was on blood pressure medications.  No treatment information was reported.   This case was linked to MOD-2021-280936 (Patient Link).
Patient received COVID vaccine Moderna 2 dose series on 2/27/21 and 3/27/21. On 8/12/2, patient presented to our facility with SOB and weakness and was admitted to the inpatient unit for COVID 19 (hx of COPD) w/out hypoxia, CHF with fluid overload, and AKI on CKD3 with hyperkalemia. As of today (8/14), patient is still admitted in the med/surg unit.
taste diminished; This spontaneous case was reported by a consumer and describes the occurrence of HYPOGEUSIA (taste diminished) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     Concomitant products included LOSARTAN POTASSIUM, AMLODIPINE, ATORVASTATIN, TIMOLOL and LATANOPROST for an unknown indication.  On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 01-Mar-2021, the patient experienced HYPOGEUSIA (taste diminished).   At the time of the report, HYPOGEUSIA (taste diminished) outcome was unknown.      Concomitant product use was not provided by the reporter. No treatment information was provided.
Patient received vaccine and approximately 15 minutes later began endorsing blurry vision and dizziness while sitting in observation room. Found to be hypertensive in 200/100s. Pt remained hypertensive and was transferred to ED about an hour after initial vaccination.
a needle was attached to a GARDASIL 9; no other adverse events reported; This spontaneous report has been received from a nurse referring a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concomitant therapies and drug allergies or reactions were not reported.   On 01-FEB-2022, a needle was attached to a HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) pre-filled syringe (product storage error) but was not administered to the patient until 25-FEB-2022 (exact dose and route were not reported, with a valid lot # T036444 and expiration date on 09-APR-2023) as prophylaxis. There were no other patients involved as a result of the attached needle. No other adverse events reported.
3 hours after administration of MMR, DTaP, and IPV, she developed an urticarial rash on chest, neck, shoulders, and to a lesser extent on back. Rash itchy; improved with Benadryl.
patient felt slightly nauseated at 10 minutes after injection, then developed slight sweating; BP 160/81; 83 at 5:45 and then 158/87 with HR 82 at 5: 52 pm.  Her lungs were clear, she was speaking in full sentences and was denying any chest pressure, her usual sense of asthma exacerbation.  At 6:05 it was 164/83 with HR 79 and patient developed a dry cough; we decided to have her wait just a bit longer, then cough worsened, so  at 6:25, decision was made to have patient seen in ER for further assessment, and en route in wheelchair to ER the dry cough became persistent, spasmodic and patient was unable to speak.  Epi-Pen was injected in right mid thigh, and patient transported to ED urgent eval.   She noted immediate palpitations, and slight improvement of breahting, was able to speak in four word sentences.  On arrival to the ED, patient was administered Duonebs, Albuterol neb, IV Benedryl, IV Solumedrol;  CXR was obtained, with results pending.  Patient was sent to observation for ongoing monitoring and assessment of breathing.  at 6:30 PM in the ER, she
my son had a very serious reaction myasthenia gravis on second shot; her son has myasthenia gravis and got his 2nd shot on her birthday date and that day he ended up in the hospital; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A male patient received COVID-19 Vaccine - Manufacturer Unknown, as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "myasthenia gravis" (unspecified if ongoing), notes: under control. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose: 1, MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: MYASTHENIA GRAVIS (hospitalization, life threatening), outcome "unknown", described as "my son had a very serious reaction myasthenia gravis on second shot"; CONDITION AGGRAVATED (hospitalization, life threatening), outcome "unknown", described as "her son has myasthenia gravis and got his 2nd shot on her birthday date and that day he ended up in the hospital". Clinical course: Caller also reports her son had a very serious reaction myasthenia gravis on second shot, admitted in medical crisis still suffering and this was also last year. Her son has myasthenia gravis and got his 2nd shot on her birthday date and that day he ended up in the hospital for the total of a month in a medical crisis. She is not sure if her son's vaccine was Moderna or Pfizer but he was at death's door. Her son had myasthenia gravis prior to the covid vaccine and it was under control but it was after the covid vaccine when he went into medical crisis. Her son had myasthenia gravis for about 6 years. The information on the batch/lot number for COVID-19 Vaccine - Manufacturer Unknown has been requested and will be submitted if and when received.
Pain and reduced ROM (R) deltoid S/P flu shot. No palpable nodule.
After immunizations were administered, patient said he was feeling fine and requested to go to the waiting room. While he and his mother were walking to the waiting room, his mother stated, "He's feeling dizzy." We were guiding him to a chair to sit down. As he was starting to sit, his body became very stiff, eyes fixed, and he was unresponsive. His body fell backwards into the chair and his head lightly hit the wall. This seizure like activity lasted around 10 seconds. He was very pale and sweaty. 911 was called. Vitals as soon as he became responsive: BP 80/40, pulse 52. Patient became alert to person, place, and surroundings again. He said he felt fine again. 911 arrived. EMS recommended he be evaluated by the local ER since he had no history of similar instances. Patient was able to walk to the ambulance. He was then taken to the ER for evaluation. Patient had not eaten breakfast that morning and he was very nervous about getting shots. I called the mother about 4:30 p.m. on 6-14-11 and she said that patient was doing fine. She said the ER ran several tests and could not find anything wrong. The ER recommended that they follow-up with a neurologist. She said after leaving the ER, they went and ate and patient ate very well. I attempted to obtain a copy of the ER report from the local hospital, but have been unsuccessful.
Information has been received from a registered nurse concerning a 20 month old white/hispanic male with no medical history and no allergies who on the morning of 5/27/03 was vaccinated IM in the left leg with an expired fourth dose of Haemophilus B conjugate vaccine (lot # 636991/1422L; expired on 5/26/03). On 5/27/03, the patient was also vaccinated with a dose of Streptococcus pneumoniae vaccine and a dose of diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid. There was no illness at the time of vaccination. There were no adverse vents following prior vaccinations. On the morning of 5/28/03 the patient developed diarrhea for 4-5 days. It was noted that no other family members had diarrhea during that time. No diagnostic studies were performed. Unspecified medical attention was sought. On 6/2/03 the patient recovered. No product quality complaint was involved.
Tired, headaches, muscle pains, chills, stiff neck, overall unwell feeling, joint pain, nauseous
Case number PHEH2016US023363, is an initial spontaneous report received from a nurse on 13 Sep 2016. This report refers to a 29 years old patient of unknown gender. Past medical history and concomitant medications were not reported. The patient was vaccinated with one single dose of FLUVIRIN (batch number: 1515701) at a dose of 0.5 ml, intramuscularly, into right arm on 01 Dec 2015. On 01 Dec 2015, FLUVIRIN MDV that had been exposed to 8 to 10 temperature excursion was administered to patient. No adverse event was reported following this medication error. The case was assessed as non-serious by the nurse.
Had chicken pox like brother 04/01/05, less than 10 lesions.
Exposure to Covid-19; This is a spontaneous report received from a contactable consumer or other non hcp. A male patient of an unspecified age received bnt162b2 (BNT162B2, Formulation: Solution for injection), dose 1 via an unspecified route of administration on 2021 as 1ST DOSE, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced exposure to covid-19 on an unspecified date in 2021. Caller reported that a repairman, the patient, came to her house to service her washer and dryer. Caller reported that the patient stated that he had the Covid-19 vaccine and was down for a week with symptoms. Outcome of the event was unknown.  Follow-up (28Apr2021): This is a follow-up spontaneous report received in response to the mail trail sent regarding the conformation below mentioned. This report included that:  Query: Can you please provide the ID as it was not provided in the narrative of the master case. Caller was warm transferred. Response: After reviewing the call recording, it is noted that the transfer agent did not provide her ID.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 70-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Nov2022 as dose 5 (booster), single (Lot number: GJ3275) at the age of 70 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "high blood pressure", start date: 2012 (ongoing), notes: high blood pressure diagnosed 10 years ago. Concomitant medication(s) included: LISINOPRIL taken for hypertension, blood pressure abnormal;     All of her previous COVID 19 vaccines have been four shots Moderna and she got the Pfizer COVID19 booster because the pharmacy did not have the Moderna booster available and said it was ok to mix them; the last booster dose of Moderna was in May and she had no side effects at all to the Moderna vaccines she received; also had a flu shot on 07Nov2022, she does not know the name of it or the manufacturer or lot, expiry date or to provide but it was at the doctor's office. Her last booster dose was in May, and it was Moderna. She had no side effects to the Moderna vaccines. She had a flu shot 10Oct2022. Her patient card has no expiry date or for the Pfizer COVID booster dose. Had no treatment for the reported events. She had a dentist's appointment she was scared to took and she did not want to put any more chemicals in her body because she does not feel well and was cancelling her dentist's appointment due to not feeling well. No investigation and conditions were reported. These events do not require a visit to Emergency room. It was reported that the case was non-serious.
Information has been received through the Merck pregnancy registry from a 25 year old female patient with no allergies and a history of three surgical procedures to remove skin cancer and gall bladder removed who on 02-JUN-2008 was vaccinated with the first dose of GARDASIL vaccine (yeast). There was no concomitant therapy. The patient was pregnant. The patient experienced the only adverse side effect as some pain in her arm in the area of the injection site. There was no fever or sickness. This only lasted fro a few days and the patient was fine now. The patient sought medical attention. Additional information has been requested.
Patient had a covid vaccine appointment at 11:20a 4/12/21.  5 minutes after administering the Janssen vaccine to patient, she alerted us stating that she was starting to feel lightheaded and nausea.  Patient was instructed to lay on her back with her feet elevated. A cold compress was also provided to her. A member of management was also notified. Her blood pressure was monitored at 125/92 at 12:10p and 123/88 at 12:30p. Calling for an ambulance was denied by patient. Patient doesn't have a primary care provider for me to inform.  Patient was with her mother who will be driving her home. Patient stayed for at least 30 minutes before leaving pharmacy.
dizziness; felt off in her head; felt sicker, and did not feel good; This is a spontaneous report received from a contactable consumer from medical information team. The reporter is the patient.  An 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 18Mar2021 (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. Relevant medical history included: "allergic to penicillin" (unspecified if ongoing); "sensitivity to some drugs" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162B2 (dose 1, Batch/Lot number: unknown), for COVID-19 immunisation, reactions: "felt disoriented", "her head was not focused right", "dizzy". The following information was reported: DIZZINESS (non-serious) with onset 19Mar2021, outcome "unknown", described as "dizziness"; FEELING ABNORMAL (non-serious) with onset 19Mar2021, outcome "unknown", described as "felt off in her head"; MALAISE (non-serious) with onset 19Mar2021, outcome "unknown", described as "felt sicker, and did not feel good".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a nurse refers to a 86 year old male patient. On 01-APR-2013 the patient was intramuscularly vaccinated with RECOMBIVAX HB, dialysis dose of 40 mcg/ml (lot # 0406AE, expiry date 25-MAR-2013) on his right deltoid. No adverse effects reported. It was unspecified if the patient had sought medical attention. Additional information has been requested.
Pt rec'd 2nd dose of vax AUG89 developed flu-like sx w/fever & aches that persisted for 1wk;
48 hours after administration, noted upper arm (DTaP and Hib) to be erythematous, blotchy, swelling, not fluctuant, not localized.
pt recvd vax; body rash, hives on arms & legs; swelling of the lips; tx: calamine lotion;
Symptom onset of 07/07 with fatigue, cough, and chest pain when coughing. She has also been diagnosed with bronchitis. She was hospitalized from 07/09 to 07/11 for observation because he doctor was concerned about her developing pneumonia. She did not develop pneumonia. She believes she caught covid at a fourth of july event at a Historic Site. She is retired and does not work. She lives with her husband who also tested positive for covid. I could not find him in sendss at this time. They have been isolating together and report no other close contacts we could reach out to. Pt did not test for the flu. She had diabetes, high blood pressure. heart conditions (a- fib), and is vulnerable to respiratory infection. She was vaccinated with Pfizer on 01/27 and 02/17.
After injection was given, there was no immediate pain.  In the afternoon, approximately 3pm, I began to feel muscle discomfort in my left shoulder/arm area where the injection was given.  In my opinion, the injection was given to far back on my shoulder near my joint and not properly given.  It was an achy kind of muscle pain, although when I rotated my shoulder, it hurt also.  I just thought it would go away.  The pain never went away and got a bit worse, in that it began to hurt down in the muscle and the joint rotation hurt more.  Flu clinic was open on Thursday, 9/24/2020, so I went to enquire as to the pain I was having and was told that was not normal and was sent to the emergency room/employee health to have it looked at. I was told that I had a "Shoulder Injury Related to Vaccination Injection".  To ice the shoulder and take Tylenol.
Administered - 14:30, Adverse event started - 14:38. Patient had syncope, flushing/sweating, dizziness. History of "blackouts during blood draws". BP 92/53 -- > 93/58y, HR 74 -- > 68, RR 18 -- > 18, O2 97% -- > 98%. Patient stable, released from vaccination site.
After injection to left Deltoid employee reports large bruise at injection site and feeling hot, dizzy. Bruising measures approximately 50 x 70 mm. NP prescribed antibiotics for cellulitis.
Pain in muscle on LD progressed muscle in neck and arm on L side progressed to R side & arm. Haven't gone to PCP. All pain in muscles aches all over now & hasn't stopped aching.
4days post injection she developed a full body rash, ears are "swollen", and throat has a funny sensations in it. Breathing normal. Treated on 2 successive days with a predinsone injection, but then was admitted for observation the next day. Treated as an inpatient for 24 hours with Solu-Medrol every 6 hours. Recovered and was released.  Patient reported that she had been previously vaccinated against COVID-19 in January, but we have no record of that (all vaccinations in Louisiana are required to be in our State Immunization Registry).
The patient developed a cough, redness, swelling and soreness at the site of the injection on 11/17/00 in the PM. The patient was seen by his family physician who prescribed cough medicine with codeine. The patient states the cough was somewhat alleviated but still complains of soreness and achiness in left arm to date.  He has trouble lifting and or reaching. Pain in the shoulder still 12/29/00.
11 y/o female patient, was being given MENACTRA, Varicella Tdap, GARDASIL. While administering HPV vaccine, patient fainted with some jerky movement x 7 secs., regain consciousness. No drooling No incontinence noted.